CNSP

CNS Pharmaceuticals, Inc.NASDAQHealthcare

$2.26+2.65%ClosedMarket Cap: $1.3M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2025-09-12	Maxim Group	upgrade	Buy	Hold

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-2.89	$50.0M	1
Sun Dec 31	$-3.33	$76.2M	1
Mon Dec 31	$-3.54	$0.00	1
Tue Dec 31	$3.78	$77.3M	1

CNSP | CNS Pharmaceuticals, Inc. Analyst Ratings & Price Target - InvestLog